Top-Line Results from DERBY and OAKS—the Good and the Bad

Charles C. Wykoff, MD, PhD

Show Description +

Charles C. Wykoff, MD, PhD, details treatment safety and efficacy of pegcetacoplan, including a reduced rate of GA growth and safety signals of intraocular inflammation and new-onset exudation.

Posted: 11/17/2021

Keywords:

Geographic Atrophy (GA)

•

Pegcetacoplan

•

Inflammation

•

retina-meeting-recap

•

Retina Subspecialty Day

Up Next

Name: Top-Line Results from DERBY and OAKS—the Good and the Bad
Uploaded: 2021-11-17T20:52:24+00:00
Description: Charles C. Wykoff, MD, PhD, details treatment safety and efficacy of pegcetacoplan, including a reduced rate of GA growth and safety signals of intraocular inflammation and new-onset exudation.

Skip 4-Week Dosing With Brolucizumab

Arshad M. Khanani, MD

Cataract Surgery in the Setting of Endothelial Dysfunction

Francis Price, MD

Premium IOL Implantation After Laser Vision Correction

Zeba Syed, MD

IOL Scaffold for the Prevention of Cataract Surgery Complications

Ashvin Agarwal, MD

Patient-Reported Outcomes With a Presbyopia Eye Drop

Cathleen M. McCabe, MD

AI’s Effect on Clinical Practice

Aaron Y. Lee, MD

Pearls for Multifocal IOL Exchange

Marjan Farid, MD

Pearls From a Senior Ophthalmologist to a Young Ophthalmologist

Marguerite McDonald, MD

AI-Guided Image Recognition for Cup-to-Disc Estimation

Dylan Stevens, MD

Home-Based Glaucoma Monitoring

Oluwatosin U. Smith, MD

Diversity and Inclusion in Ophthalmology and Its Potential Effects on Patient Care

Fasika A. Woreta, MD, MPH

Change in IOP Following Standalone Phacoemulsification

Adam Rothman, MD

Preparing for Same-Day Bilateral Cataract Surgery

Presbyopia-Correcting IOLs: Pearls and Pitfalls

William B. Trattler, MD

Saving Time With an Intracanalicular Dexamethasone Insert

Updates on Subretinal/Suprachoroidal Gene Therapy for Wet AMD

Robert Avery, MD

A Peek at the Latest Surgical Instruments

David R. Chow, MD

AI Screening Models for DR Go Head-to-Head

Aaron Y. Lee, MD

Using OCT To Predict and Track AMD Progression

Srinivas R. Sadda, MD

Promising Findings with Transplanted RPE Cells for Patients with GA

Michael S. Ip, MD

Updates on Subretinal/Suprachoroidal Gene Therapy for Wet AMD

Robert Avery, MD

Back to All Videos

Top-Line Results from DERBY and OAKS—the Good and the Bad

Charles C. Wykoff, MD, PhD

Charles C. Wykoff, MD, PhD, details treatment safety and efficacy of pegcetacoplan, including a reduced rate of GA growth and safety signals of intraocular inflammation and new-onset exudation.

Posted: 11/17/2021

Keywords:

Geographic Atrophy (GA)

•

Pegcetacoplan

•

Inflammation

•

retina-meeting-recap

•

Retina Subspecialty Day

Please log in to leave a comment.

Meeting Coverage:

American Academy of Ophthalmology

Top-Line Results from DERBY and OAKS—the Good and the Bad

Up Next

Top-Line Results from DERBY and OAKS—the Good and the Bad

More From AAO: 2021 Coverage